Nachwuchsforschende und Projektleiterinnen und Projektleiter werden in Kurzvorträgen die wichtigsten und spannendsten Erkenntnisse ihrer Forschungsarbeit zu seltenen Krankheiten präsentieren.
Keynote Lecture: «The changing face of genetics: Diagnostics to therapy»
Prof. Han Brunner, Maastricht UMC
Hörsaal Kinderspital Zürich
30.11.2017 | 14-18h
Hier geht es zum Programm: >>>
Hier zum Flyer: >>>
Zum Programm geht es hier >>>
Anmeldungen bis 31.10.2017 an fzk((AT))kispi((DOT))uzh.ch
With the special programme Investigator Initiated Clinical Trials (IICT), the SNSF is promoting clinical studies in under-researched areas that do not attract industry interest. The call is limited to prospective, randomised, controlled and multicentric intervention studies.
Researchers who intent to participate send a letter of intent to the SNSF by September 1, 2017.
The deadline for the submission of applications is November 1, 2017.
Details are given on the SNSF website >>>
The National Research Council has approved seven investigator initiated clinical trials. You find the winners of the 2nd IICT call here >>>
We congratulate the team of the UKBB for their successful application!
The third IICT call will be launched in mid-July 2017.
The IICT programme from the SNSF is targeted at researchers who wish to conduct an independent investigator initiated clinical trial. Support will be given to studies that are not in the industry focus and whose topics are as yet under-researched.
There will be one call each year, up to and including 2020.
SPHN is launching its first call for proposals aimed at the development of a national interoperable research infrastructure ecosystem for competitive personalized health research.
SPHN Grants will be awarded to projects aiming at the development, implementation and validation of a data infrastructures that allow connecting research institutions and hospitals in order to share and use health-related data across Switzerland.
Deadline for submission: 15 September 2017
Detailed information you find here >>>
They are searching for existing drug repurposing ideas for rare diseases that have yet to receive a full clinical trial. Their primary aim is to demonstrate the huge potential of clinic-led, patient group-led, and researcher-driven innovation in drug repurposing for rare diseases, and the need for new funding streams to help these ideas bridge the translational gap, including Findacure’s Rare Disease Drug Repurposing Social impact Bond (RDDR SIB).
Ideal projects will have some form of collaborator in the UK (note: the PI is not required to be based in the UK), and multinational clinical trials are welcome. For additional eligibility criteria and further information >>>
Deadline for submissions: May, 31 2017
The objective of this call is to support the multinational extension of paediatric studies on medicinal products having already secured funding in the coordinating country.
Hence, if you have a protocol already accepted for funding in Switzerland but you need funding to go abroad, then this call is perfect for you!
All 18 member countries of the PedCRIN consortium are eligible.
Submission deadline: May 2, 2017 | 17.00h CET
The 5th radiz Rare Diseases Summer School will take place in the Tagungszentrum Schloss Au, Wädenswil (on lake Zurich), from June 7th to June 9th 2017.
A wide variety of subjects in the arena of rare diseases will be covered. There will be lectures by national and international rare disease experts, workshops, and poster presentations by participants. Subjects include drug development, model organisms, how to choose clinical endpoints, clinical trials, regulatory aspects, patient registries, patient initiated research, ethical considerations, as well as what rare diseases may tell us about common diseases.
radiz Summer School Flyer >>>
radiz Summer School Program >>>
Please refer to the website for current information.
The application deadline is February 27, 2017.
University Children's Hospital (Universitäts-Kinderspital beider Basel, UKBB), Basel, Switzerland will hold the 3rd annual event for interdisciplinary challenges, preceded by a master class on commercial drug development in the morning of February 1, and a master class on Pediatric Drug development in the afternoon of February 1.
Registration is possible from now on >>>. A first draft agenda and further updates will be sent out in the next weeks and months.
Johannes van den Anker and Klaus Rose, as well as the organizing institutions, are looking forward to welcoming you at DMPRD at the Kinderspital beider Basel.
PELICAN Paediatric End-of-Life Care Needs in Switzerland:
In dieser Tagung werden die Ergebnisse der PELICAN-Studie vorgestellt und Empfehlungen für eine adäquate Gesundheitsversorgung im Bereich der Pädiatrischen Palliative Care diskutiert.
Hier geht es zum Flyer >>>
Nähere Informationen finden Sie hier >>>